PRL and neoplasm: Tumor type was: (1) NFPA in 65 patients (27%), (2) ACRO in 41 patients (17%), (3) CD in 32 patients (13%), (4) PRL in 97 patients (40%), and (5) RCC in 6 patients (3%).